Income statement, balance sheet and cash flow statement for the last 3 fiscal years, taken from the XBRL data Ralliant Corp files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2023
FY2025
FY2025
Revenue
2,156
2,155
2,069
Cost of revenue
1,036
1,043
1,029
Gross profit
1,120
1,112
1,040
Research and development
162
164
165
Selling, general and administrative
446
552
617
Operating expenses
608
716
782
Operating income
512
460
-1,183
Interest expense
0
0
32.3
Other non-operating income
-2
-1.4
-1.1
Pre-tax income
510
433
-1,216
Income tax
93
78
6.1
Net income
417
355
-1,223
EBITDA
543
573
-1,068
EPS, basic
3.70
3.15
-10.84
EPS, diluted
3.70
3.15
-10.84
Shares, basic (weighted)
113
113
113
Shares, diluted (weighted)
113
113
113
Dividend per share
0.10
Balance sheet
FY2023
FY2025
FY2025
Cash and equivalents
0
0
319
Receivables
294
285
Inventory
283
302
Other current assets
1.1
13.7
Total current assets
619
976
Property, plant and equipment
200
214
Lease right-of-use assets
72.4
68.4
Goodwill
1,857
2,940
1,672
Intangible assets
810
795
Other non-current assets
151
164
Total assets
4,719
3,822
Accounts payable
255
264
Accrued liabilities
279
366
Deferred revenue
143
155
Short-term debt
0
530
Total current liabilities
534
1,160
Long-term debt
0
618
Lease liabilities
59.7
58.1
Other non-current liabilities
423
409
Total liabilities
957
2,187
Total debt
0
1,149
Paid-in capital
0
3,223
Retained earnings
0
-1,345
Treasury stock
0
Other comprehensive income
-491
-245
Shareholders' equity
2,261
3,763
1,634
Total equity
2,261
3,763
1,634
Total liabilities and equity
4,719
3,822
Shares outstanding
0
113
Cash flow statement
FY2023
FY2025
FY2025
Net income
417
355
-1,223
Depreciation and amortization
30.7
113
116
Stock-based compensation
25
24.5
56.2
Change in receivables
9.3
8.7
15.2
Change in inventory
-10.3
16.7
-13
Cash from operations
462
455
398
Capital expenditures
-29.2
-34.3
-39.2
Acquisitions
0
-1,718
0
Cash from investing
-22.4
-1,707
-37.7
Debt issued
0
0
1,147
Stock issued
2.1
Dividends paid
0
0
-11.3
Cash from financing
-432
1,261
-54.7
Net change in cash
0
0
319
Free cash flow
433
420
358
Income taxes paid
74.2
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to July 3, 2026; growth uses fiscal years. Valuation uses the share price of $70.03 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
50.9%
Gross profit / revenue.
Operating margin
-53.3%
Operating income / revenue.
EBITDA margin
-47.8%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-56.1%
Pre-tax income / revenue.
Net margin
-56.4%
Net income / revenue.
FCF margin
15.0%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
16.7%
Cash from operations / revenue.
Return on equity (ROE)
-80.4%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-33.3%
Net income / average total assets.
Return on invested capital (ROIC)
-38.2%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
7.8%
Research and development expense / revenue.
SG&A / revenue
30.5%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
3.0%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
1.7%
Capital expenditures / revenue.
D&A / revenue
5.5%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-4.0%
Revenue vs the same period a year earlier. Only from a positive base.
Gross profit growth, 1y
-6.5%
Gross profit vs the same period a year earlier. Only from a positive base.
Operating income growth, 1y
-357.4%
Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y
-286.4%
EBITDA vs the same period a year earlier. Only from a positive base.
Net income growth, 1y
-444.8%
Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y
-444.1%
EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y
-12.5%
Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y
-14.7%
Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y
-56.6%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
-19.0%
Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y
0.1%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.52x
Current assets / current liabilities.
Quick ratio
0.88x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.42x
(Cash + short-term investments) / current liabilities.
Debt / equity
0.75x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
31.0%
Total debt / total assets.
Liabilities / assets
58.6%
Total liabilities / total assets.
Net debt
$877.6M
Total debt - cash - short-term investments. Negative means more cash than debt.
Days inventory + days sales outstanding - days payables.
Capex / operating cash flow
10.2%
Capital expenditures / cash from operations, when that is positive.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$10.95
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$19.41
Revenue / diluted weighted shares.
FCF per share
$2.91
Free cash flow / diluted weighted shares.
Operating cash flow per share
$3.24
Cash from operations / diluted weighted shares.
Book value per share
$13.87
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Dividends paid / free cash flow, when free cash flow is positive.
Valuation
Metric
Value
How it is calculated
Market cap
$7.75B
Share price x shares outstanding.
Enterprise value
$8.63B
Market cap + total debt - cash - short-term investments.
P/S
3.54x
Market cap / revenue.
P/B
5.05x
Market cap / shareholders' equity. Only when equity is positive.
P/FCF
23.6x
Market cap / free cash flow. Only when free cash flow is positive.
P/OCF
21.2x
Market cap / cash from operations, when positive.
EV/Sales
3.95x
Enterprise value / revenue.
EV/FCF
26.3x
Enterprise value / free cash flow, when both are positive.
FCF yield
4.2%
Free cash flow / market cap.
Earnings yield
-15.9%
Net income / market cap (the inverse of P/E).
Dividend yield
0.3%
Dividends paid over the period / market cap.
Shareholder yield
0.3%
(Dividends paid + share buybacks) / market cap.
What was Ralliant Corp's revenue in fiscal 2025?
Ralliant Corp reported revenue of $2.07B for fiscal 2025, 4% lower than the year before.
Was Ralliant Corp profitable in fiscal 2025?
No. It reported a net loss of $1.22B.
How much free cash flow did Ralliant Corp generate in fiscal 2025?
Cash from operations of $397.6M minus capital expenditures of $39.2M left free cash flow of $358.4M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.